Patents Assigned to Isomerase Therapeutics Ltd.
  • Methods for increasing molecular diversity of polyketides and non-ribosomal proteins
    Patent number: 9976165
    Abstract: A method for increasing the molecular diversity of polyketides and non-ribosomal peptides by using recombination to efficiently increase or decrease the number of modules in the polyketide synthase or non-ribosomal peptide synthetase encoding the polyketide or peptide.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: May 22, 2018
    Assignee: ISOMERASE THERAPEUTICS, LTD.
    Inventors: Matthew Alan Gregory, Steven Gary Kendrew, Steven James Moss, Barrie Wilkinson
  • METHODS FOR INCREASING MOLECULAR DIVERSITY OF POLYKETIDES AND NON-RIBOSOMAL PROTEINS
    Publication number: 20170101659
    Abstract: A method for increasing the molecular diversity of polyketides and non-ribsomomal peptides by using recombination to efficiently increase or decrease the number of modules in the polyketide synthase or non-ribosomal peptide synthetase encoding said polyketide or peptide.
    Type: Application
    Filed: July 9, 2014
    Publication date: April 13, 2017
    Applicant: ISOMERASE THERAPEUTICS LTD.
    Inventors: Matthew Alan Gregory, Steven Gary Kendrew, Steven James Moss, Barrie Wikinson
  • Rapamycin analogues and their pharmaceutical use
    Patent number: 9505773
    Abstract: Novel rapamycin analogues and methods for their production with FKBP and/or MIP inhibitory activity with reduced mTOR inhibitory activity with therapeutic potential e.g. as bacterial virulence inhibitors.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: November 29, 2016
    Assignee: Isomerase Therapeutics Ltd.
    Inventors: Matthew Alan Gregory, Steven Gary Kendrew, Steven James Moss, Barrie Wilkinson